Part I - The Schedule Section B - Supplies or Services and Prices/Costs (November 9th, 2016)
Emergent Product Development Gaithersburg Inc. is developing NuThrax vaccine as a next generation anthrax vaccine. This vaccine is intended to mitigate anthrax as a bio threat against civilian populations suitable for Post-Exposure Prophylaxis (PEP) as a priority medical countermeasure.
Supply Agreement (March 11th, 2011)
This Agreement is made effective as of the first day of January 2011 (the "Effective Date") by and between Hollister-Stier Laboratories LLC, having a principal place of business at 3525 North Regal Street, Spokane, Washington, 99207-5788 ("Hollister-Stier") and Emergent BioDefense Operations Lansing LLC, having a principal place of business at 3500 North Martin Luther King Jr. Blvd., Lansing, Michigan 48906 ( "EBOL"). Both Hollister-Stier and EBOL are referred to herein individually as "Party" and collectively as the "Parties."